TFF Pharmaceuticals, Inc. Rings the Opening Bell
ABOUT THIS EVENT
TFF Pharmaceuticals, Inc. (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Glenn Mattes, President & CEO, rang the Opening Bell.